Literature DB >> 15344592

Vascular involvement in systemic sclerosis (SSc).

M B Kahaleh1.   

Abstract

The vascular endothelium came into view almost three decades ago following the introduction of the vascular hypothesis in scleroderma pathogenesis by Dr LeRoy. Since that time, the endothelial cells, and other vascular cells, became the focus of investigations aimed at eludicating the etiology, pathogenesis and treatment of scleroderma. This review will summarize Dr LeRoy's commitment to the disease, the relevant progress made since the introduction of the vascular hypothesis, and what we have learned since then about the vascular disease in scleroderma.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15344592

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  19 in total

1.  Mean platelet volume seems to be a valuable marker in patients with systemic sclerosis.

Authors:  Serdar Soydinc; Ibrahim Halil Turkbeyler; Yavuz Pehlivan; Gulcimen Soylu; Mehmet Fatih Goktepe; Muhammed Bilici; Orhan Zengin; Bunyamin Kisacik; Ahmet Mesut Onat
Journal:  Inflammation       Date:  2014-02       Impact factor: 4.092

Review 2.  [Raynaud phenomenon in dermatology. Part 1: Pathophysiology and diagnostic approach].

Authors:  C Sunderkötter; G Riemekasten
Journal:  Hautarzt       Date:  2006-09       Impact factor: 0.751

Review 3.  Microvascular damage in systemic sclerosis: detection and monitoring with biomarkers.

Authors:  Laura K Hummers
Journal:  Curr Rheumatol Rep       Date:  2006-04       Impact factor: 4.592

4.  Lack of association between three vascular endothelial growth factor gene polymorphisms and systemic sclerosis: results from a multicenter EUSTAR study of European Caucasian patients.

Authors:  Y Allanore; D Borderie; P Airo; S Guiducci; L Czirják; E L Nasonov; G Riemekasten; P Caramaschi; M Majdan; D Krasowska; E Friedl; H Lemarechal; L P Ananieva; T Nievskaya; O G Ekindjian; M Matucci-Cerinic; A Kahan
Journal:  Ann Rheum Dis       Date:  2006-06-01       Impact factor: 19.103

5.  Angiographic characteristics of vasculopathy in patients with idiopathic inflammatory myopathies and systemic sclerosis.

Authors:  Jina Yeo; Eun-Ah Park; Eun Bong Lee; Jin Kyun Park
Journal:  Sci Rep       Date:  2022-05-31       Impact factor: 4.996

6.  Penile involvement in Systemic Sclerosis: New Diagnostic and Therapeutic Aspects.

Authors:  Antonio Aversa; Roberto Bruzziches; Davide Francomano; Edoardo Rosato; Felice Salsano; Giovanni Spera
Journal:  Int J Rheumatol       Date:  2010-10-05

7.  Risk of Pulmonary Embolism and Deep Venous Thrombosis in Systemic Sclerosis: A General Population-Based Study.

Authors:  Sara R Schoenfeld; Hyon K Choi; Eric C Sayre; J Antonio Aviña-Zubieta
Journal:  Arthritis Care Res (Hoboken)       Date:  2016-02       Impact factor: 4.794

8.  The vascular microenvironment and systemic sclerosis.

Authors:  Tracy Frech; Nathan Hatton; Boaz Markewitz; Mary Beth Scholand; Richard Cawthon; Amit Patel; Allen Sawitzke
Journal:  Int J Rheumatol       Date:  2010-08-10

9.  Serum endoglin levels in patients suffering from systemic sclerosis and elevated systolic pulmonary arterial pressure.

Authors:  Paola Ximena Coral-Alvarado; Maria Fernanda Garces; Jorge Eduardo Caminos; Antonio Iglesias-Gamarra; José Félix Restrepo; Gerardo Quintana
Journal:  Int J Rheumatol       Date:  2010-08-24

10.  Proteinase activated receptor-2 counterbalances the vascular effects of endothelin-1 in fibrotic tight-skin mice.

Authors:  Fiorentina Roviezzo; Vincenzo Brancaleone; Valentina Mattera Iacono; Antonio Bertolino; Giovanna De Cunto; Valentina Vellecco; Giuseppe Lungarella; Monica Lucattelli; Giuseppe Cirino
Journal:  Br J Pharmacol       Date:  2016-10-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.